CC PACKET 07252023 - Laserfiche WebLink

Home Browse Search

ORDINANCE 2023-03 4 license will be for March 15th of the year of the issuance to March 14th of the following year or other such time frame as specified. (B) Basis for Denial of License. (1) Grounds for denying the issuance or renewal of a license include, but are not limited to, the following: (a)The applicant is under 21 years of age. (b)The applicant has been convicted within the past five years of any violation of federal, state, or local law, ordinance provision, or other regulation relating to cannabinoid products. (c)The applicant has had a license to sell cannabinoid products suspended or revoked within the preceding 12 months of the date of application. (d)The applicant fails to provide any of the information required on the licensing application, or provides false or misleading information. (e)The applicant is prohibited by federal, state, or other local law, ordinance, or other regulation from holding a license. (f)The business for which the license is requested is a moveable place of business. Only fixed-location retail establishments that are not excluded under the definition for retail establishments in this ordinance are eligible to be licensed. (2) Location Ineligible. No license will be approved unless the premises proposed to be licensed complies with all applicable zoning requirements. (C)Issued Mistakenly. If a license is mistakenly issued or renewed to a person, the City will revoke the license upon the discovery that the person was ineligible for the license under this ordinance. The City will provide the license holder with notice of the revocation, along with information on the right to appeal. Section 111.064. Sales of Cannabinoids Derived from Hemp. In accordance with Minn. Stat. § 151.72, Subd.3, as may be amended: (A)A product containing nonintoxicating cannabinoids, including an edible cannabinoid product, may be sold for human or animal consumption only if all of the requirements of this section are met, provided that a product sold for human or animal consumption does not contain more than 0.3 percent of any tetrahydrocannabinol and an edible cannabinoid product does not contain more than five milligrams of any tetrahydrocannabinol in a single serving, or more than a total of 50 milligrams of any tetrahydrocannabinol per package. (B)No other substance extracted or otherwise derived from hemp may be sold for human consumption if the substance is intended: (1)For external or internal use in the diagnosis, cure, mitigation, treatment, or